Abstract/Details

Pharmacokinetic and Pharmacodynamic Characterization of a Sphingosine 1-phosphate Receptor Antagonist Prodrug


2011 2011

Other formats: Order a copy

Abstract (summary)

Sphingosine 1-phosphate (S1P) is a phospholipid that binds to a set of G protein-coupled receptors (S1P1 – S1P5) to initiate an array of signaling cascades that impact cell survival, differentiation, proliferation, and migration. On a larger physiological scale, the effects of S1P on immune cell trafficking, vascular barrier integrity, angiogenesis, and heart rate have also been observed. An impetus for the characterization of S1P-initiated signaling effects came with the discovery that FTY720 (Fingolimod) modulates the immune system by acting as an agonist at S1P1. In the course of structure-activity relationship studies to understand better the functional chemical space around FTY720, we discovered conformationally-constrained FTY720 analogs that behave as S1P receptor (S1PR) type-selective antagonists. Here we present a pharmacological profile of a lead S1P1/3 antagonist prodrug, 1-(hydroxymethyl)-3-(3-octylphenyl)cyclobutane (VPC03090). VPC03090 is phosphorylated by sphingosine kinase 2 to form the competitive antagonist species, 3-(3-octylphenyl)-1-(phosphonooxymethyl)cyclobutane (VPC03090-P) as observed in GTP[gamma-35S] binding assays, with effects on downstream S1PR signaling confirmed by Western blot and calcium mobilization assays. Oral dosing of VPC03090 results in an approximate 1:1 phosphorylated : alcohol species ratio with a half-life of 30 hours in mice. As aberrant S1P signaling has been implicated in carcinogenesis, we applied VPC03090 in an immunocompetent mouse mammary cancer model to assess its anti-neoplastic potential. Treatment with VPC03090 significantly inhibited the growth of 4T1 primary tumors in mice. This result calls to attention the value of 51PR antagonists as not only research tools but also potential therapeutic agents.

Indexing (details)


Subject
Pharmacology;
Oncology
Classification
0419: Pharmacology
0992: Oncology
Identifier / keyword
Health and environmental sciences; Antagonist; Cancer; Prodrugs; Receptor; Sphingosine 1-phosphate
Title
Pharmacokinetic and Pharmacodynamic Characterization of a Sphingosine 1-phosphate Receptor Antagonist Prodrug
Author
Kennedy, Perry Courtland
Number of pages
207
Publication year
2011
Degree date
2011
School code
0246
Source
DAI-B 73/02, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
ISBN
9781267009319
Advisor
Lynch, Kevin
University/institution
University of Virginia
University location
United States -- Virginia
Degree
Ph.D.
Source type
Dissertations & Theses
Language
English
Document type
Dissertation/Thesis
Dissertation/thesis number
3484635
ProQuest document ID
903287338
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
http://search.proquest.com/docview/903287338
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.